Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.86 USD | +5.12% | +1.81% | -10.00% |
Apr. 16 | Precision BioSciences Opts to Regain Rights to 3 Programs From Eli Lilly Unit Collaboration | MT |
Apr. 16 | Transcript : Precision BioSciences, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- DTIL Stock
- News Precision BioSciences, Inc.
- Goldman Sachs Adjusts Price Target on Precision BioSciences to $1 From $2, Maintains Neutral Rating